Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2021/7809231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850209275700314112 |
|---|---|
| author | Rebecca A. Ocher Erika Padilla Jonathan C. Hsu Pam R. Taub |
| author_facet | Rebecca A. Ocher Erika Padilla Jonathan C. Hsu Pam R. Taub |
| author_sort | Rebecca A. Ocher |
| collection | DOAJ |
| description | A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors’ knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients. |
| format | Article |
| id | doaj-art-923acc0dca654f6492ee970825cbf6f9 |
| institution | OA Journals |
| issn | 2090-6404 2090-6412 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Cardiology |
| spelling | doaj-art-923acc0dca654f6492ee970825cbf6f92025-08-20T02:10:03ZengWileyCase Reports in Cardiology2090-64042090-64122021-01-01202110.1155/2021/78092317809231Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 InfectionRebecca A. Ocher0Erika Padilla1Jonathan C. Hsu2Pam R. Taub3Department of Medicine, University of California, Los Angeles, Los Angeles, California, USADivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, California, USADivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, California, USADivision of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, California, USAA 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors’ knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients.http://dx.doi.org/10.1155/2021/7809231 |
| spellingShingle | Rebecca A. Ocher Erika Padilla Jonathan C. Hsu Pam R. Taub Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection Case Reports in Cardiology |
| title | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
| title_full | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
| title_fullStr | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
| title_full_unstemmed | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
| title_short | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
| title_sort | clinical and laboratory improvement in hyperadrenergic postural orthostatic tachycardia syndrome pots after covid 19 infection |
| url | http://dx.doi.org/10.1155/2021/7809231 |
| work_keys_str_mv | AT rebeccaaocher clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT erikapadilla clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT jonathanchsu clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT pamrtaub clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection |